IT8048997A0 - 4-aroilimidazol-2-oni dotati di pro prieta' anti-ipertensive cardiotoniche e antitrombotiche e procedimento per la loro preparazione - Google Patents

4-aroilimidazol-2-oni dotati di pro prieta' anti-ipertensive cardiotoniche e antitrombotiche e procedimento per la loro preparazione

Info

Publication number
IT8048997A0
IT8048997A0 IT8048997A IT4899780A IT8048997A0 IT 8048997 A0 IT8048997 A0 IT 8048997A0 IT 8048997 A IT8048997 A IT 8048997A IT 4899780 A IT4899780 A IT 4899780A IT 8048997 A0 IT8048997 A0 IT 8048997A0
Authority
IT
Italy
Prior art keywords
aroilimidazol
cardiotonic
ons
hypertensive
procedure
Prior art date
Application number
IT8048997A
Other languages
English (en)
Other versions
IT1143922B (it
Inventor
Richard A Schnettler
Richard C Dage
Grisar J Martin
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26727558&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT8048997(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of IT8048997A0 publication Critical patent/IT8048997A0/it
Application granted granted Critical
Publication of IT1143922B publication Critical patent/IT1143922B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IT48997/80A 1979-06-18 1980-06-17 4-aroilimidazol-2-oni dotati di proprieta'anti-ipertensive cardiotoniche e antitrombotiche e procedimento per la loro preparazione IT1143922B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4980879A 1979-06-18 1979-06-18
US11920780A 1980-02-07 1980-02-07

Publications (2)

Publication Number Publication Date
IT8048997A0 true IT8048997A0 (it) 1980-06-17
IT1143922B IT1143922B (it) 1986-10-29

Family

ID=26727558

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48997/80A IT1143922B (it) 1979-06-18 1980-06-17 4-aroilimidazol-2-oni dotati di proprieta'anti-ipertensive cardiotoniche e antitrombotiche e procedimento per la loro preparazione

Country Status (20)

Country Link
AT (1) AT375349B (it)
AU (1) AU532783B2 (it)
CA (1) CA1132554A (it)
CH (1) CH646155A5 (it)
DE (1) DE3021792A1 (it)
DK (1) DK160269C (it)
ES (1) ES8105299A1 (it)
FR (1) FR2459233A1 (it)
GB (1) GB2055364B (it)
HK (1) HK61486A (it)
HU (1) HU186736B (it)
IE (1) IE50646B1 (it)
IL (1) IL60243A (it)
IT (1) IT1143922B (it)
MY (1) MY8600709A (it)
NL (2) NL193752C (it)
NO (1) NO152841C (it)
NZ (1) NZ193935A (it)
PH (1) PH18683A (it)
SE (2) SE447107B (it)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones
US4405628A (en) * 1981-03-05 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Pyridylimidazolones and method of use
US4329471A (en) * 1981-05-04 1982-05-11 Merrell Dow Pharmaceuticals Inc. 4-(4-Phenyl-1-piperidinyl)methyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones
US4371737A (en) * 1981-05-04 1983-02-01 Merrell Dow Pharmaceuticals Inc. 5-Aminomethyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives
US4329470A (en) 1981-05-04 1982-05-11 Merrell Dow Pharmaceuticals Inc. 5-(4-Phenyl 1-piperidinyl)methyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives
ZA822990B (en) * 1981-05-04 1983-03-30 Merrell Dow Pharma 4-oxymethyl-5-acyl-1,3-dihydro-2h-imidazol-2-ones
US4526981A (en) * 1981-05-04 1985-07-02 Merrell Dow Pharmaceuticals Inc. [1,2-Dihydro-4(5)-acyl-2-oxo-2H-imidazol-4(5)-yl] methyl nitrates
US4381393A (en) * 1981-05-04 1983-04-26 Merrell Dow Pharmaceuticals Inc. 4-Aminomethyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones
US4367236A (en) 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US4410540A (en) * 1981-11-04 1983-10-18 Merrell Dow Pharmaceuticals Inc. Cardiotonic 4-aroylimidazolidin-2-ones
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
JP2007530566A (ja) * 2004-03-22 2007-11-01 ミオゲン インコーポレイティッド (r)−エノキシモンスルホキシドおよびpde−iii媒介疾患の治療におけるその使用
CA2560528A1 (en) * 2004-03-22 2005-10-06 Myogen, Inc. (s) - enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
JP2009514969A (ja) 2005-11-09 2009-04-09 コンビナトアールエックス インコーポレーティッド 医学的状態を治療するための方法、組成物、およびキット
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
DK2681236T3 (en) 2011-03-01 2018-04-16 Synergy Pharmaceuticals Inc PROCEDURE FOR MANUFACTURING GUANYLATE CYCLASE-C-AGONISTS
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
WO2014131024A2 (en) 2013-02-25 2014-08-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
AU2014305843B2 (en) 2013-08-09 2019-08-29 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
EP4706758A3 (en) 2019-05-21 2026-05-06 Ardelyx, Inc. Methods for inhibiting phosphate transport
CN114539157B (zh) * 2022-03-03 2023-12-22 曲靖师范学院 一种碘促进氧化法制备4-碘代n-芳基吡唑类化合物的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them

Also Published As

Publication number Publication date
SE447107B (sv) 1986-10-27
CA1132554A (en) 1982-09-28
AU5911880A (en) 1981-01-08
SE464559B (sv) 1991-05-13
PH18683A (en) 1985-08-29
NL193752B (nl) 2000-05-01
NO801796L (no) 1980-12-19
AU532783B2 (en) 1983-10-13
AT375349B (de) 1984-07-25
CH646155A5 (de) 1984-11-15
IT1143922B (it) 1986-10-29
FR2459233B1 (it) 1983-09-23
DE3021792A1 (de) 1981-01-22
NL300015I2 (nl) 2000-10-02
IL60243A (en) 1987-01-30
HU186736B (en) 1985-09-30
DK259080A (da) 1980-12-19
SE8501452L (sv) 1985-03-25
DK160269B (da) 1991-02-18
IL60243A0 (en) 1980-09-16
DE3021792C2 (it) 1989-08-10
NO152841B (no) 1985-08-19
GB2055364A (en) 1981-03-04
NZ193935A (en) 1985-05-31
NL8003498A (nl) 1980-12-22
IE50646B1 (en) 1986-06-11
GB2055364B (en) 1983-06-08
NO152841C (no) 1985-11-27
ES492255A0 (es) 1981-06-01
HK61486A (en) 1986-08-29
NL300015I1 (nl) 2000-11-01
ES8105299A1 (es) 1981-06-01
ATA314280A (de) 1983-12-15
SE8004253L (sv) 1980-12-19
IE801162L (en) 1980-12-18
MY8600709A (en) 1986-12-31
SE8501452D0 (sv) 1985-03-25
FR2459233A1 (fr) 1981-01-09
DK160269C (da) 1991-07-22
NL193752C (nl) 2000-09-04

Similar Documents

Publication Publication Date Title
IT8048997A0 (it) 4-aroilimidazol-2-oni dotati di pro prieta' anti-ipertensive cardiotoniche e antitrombotiche e procedimento per la loro preparazione
IT1144079B (it) Nuovi derivati piperidinici dotati di proprieta' antiistaminiche antiallergiche e broncodilatatrici e procedimento per la loro preparazione
ES525743A0 (es) Procedimiento para la fabricacion de 4'-demetil-epipodofilotoxin-b-d-etiliden-glucosido y derivado acilico del mismo
IT8048000A0 (it) Composti eterociclici dotati di pro prieta' farmacologiche e procedimento per la loro preparazione
IT1209254B (it) Procedimento per rilevare perdite in condutture e apparecchiature per l'attuazione del procedimento.
IT8148261A0 (it) Ammidi dotate di proprieta' farmaceutiche e loro preparazione
NO802843L (no) Fremgangsmaate for fremstilling av aktivt karbon i fibroes form
IT1171520B (it) Procedimento per la preparazione di 2-ammino-3-carbetossiammino-6-(p-fluor-benzilammino)-piridin-maleato dotato di proprieta' farmacologiche e prodotto ottenuto
GB2066812B (en) 5'-acyl-uridine derivatives and processes for the preparation thereof
TR21520A (tr) Alkil tert-alkil'in terkibine coezuelmesi icin usul
IT8023649A0 (it) Procedimento per migliorare la proprieta' di leghe.
TR20746A (tr) Homoserin tuerevleri,bunlarin hazirlanisi icin usul ve bunlarin mikrobisidler olarak kullanilmalari
IT1162395B (it) Derivati auronici dotati di attivita' farmacologica e procedimento per la loro preparazione
IT8083420A0 (it) Derivati d'amino-14 steroidi e procedimento per la loro preparazione.
IT1141392B (it) Procedimento di trasformazione dell'idrargillite in boemite
IT1143921B (it) Derivati di acidi alcanoici dotati di proprieta' terapeutiche e procedimento per la loro preparazione
IT1165040B (it) Alcossialchilidenidrazinopiridazione e procedimento per la loro preparazione
IT1174296B (it) Derivati di tallisomicina semibiosintetici dotati di prorieta'antimicrobiche ed anti-tumorali e procedimento per la loro preparazione
BE879732A (fr) Derives d'acyl-1h-1,2,4-triazole, leur preparation et leur utilisation
IT8048485A0 (it) Derivati alfa-alogenometilamminici dotati di attivita' farmacologica eprocedimento per la loro preparazione
IT1145339B (it) Acidi-6ammino-spiro(penam-2,4'-piperidino)-3-carbossilici e loro procedimento di preparazione
GB2058774B (en) 6''-deoxydibekacin-4''6''-dideoxydibe kacin and 1-n-aminoacyl derivatives thereof and their production
IT1148788B (it) Derivati dell'amminoisochinolina e procedimento per la loro preparazione
IT1130215B (it) 3-ariltio-4-idrossipirrolidine 1-sostituite e procedimento per la loro preparazione
IT1102595B (it) Benzomorfani sostitutti dotati di proprieta' farmacologiche e procedimento per la loro preparazione

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 156

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 156, 19920424; MERREL DOW PHARMACEUTICALS INC.

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950419